Tocagen Inc·4

Oct 4, 8:36 PM ET

Kabbinavar Fairooz 4

4 · Tocagen Inc · Filed Oct 4, 2019

Insider Transaction Report

Form 4
Period: 2019-10-04
Kabbinavar Fairooz
SVP Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-10-04+20,00020,000 total
    Exercise: $0.64Exp: 2029-10-03Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION